Skip to main content
Premium Trial:

Request an Annual Quote

Helicos BioSciences Joins Personalized Medicine Coalition

NEW YORK (GenomeWeb News) - Helicos BioSciences has joined the Personalized Medicine Coalition, the company said today.
“Living in an era where patients will have the opportunity to have their genome sequenced, it’s essential for us to join the discussion on how society will deal with this scientific breakthrough,” Patrice Milos, Helicos’ chief scientific officer, said in a statement.
Founded in 2004, the PMC is an advocacy group aimed at “advancing the understanding and adoption of personalized medicine.”
Last week Helicos said its single-molecule sequencing system, the HeliScope, will have a list price of $1.35 million — more than double the price of the most expensive next-generation sequencer on the market to date — GenomeWeb Daily News sister publication In Sequence reports this week.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.